A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation) (Q85015607)

From Wikidata
Jump to navigation Jump to search
scientific article published on 19 September 2012
edit
Language Label Description Also known as
English
A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation)
scientific article published on 19 September 2012

    Statements

    title
    A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation) (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    22999717
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22999717%20AND%20SRC:MED&resulttype=core&format=json
    retrieved
    13 February 2020
    author

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q85015607&oldid=2079334255"